Home/Project news/PREV_PKDL project strengthens flow cytometry capacity in Africa
The PREV_PKDL project aims to advance the clinical development of ChAd63-KH vaccine for the prevention of post kala azar dermal leishmaniasis (PKDL). One of activities of the project is strengthening immunology research capacity in East Africa by promoting the development of a flow cytometry Centre of Excellence. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology and infectious disease monitoring. Flow cytometers were installed at four African sites: Institute of Endemic Diseases (IEND), Sudan; Kenya Medical Research Institute (KEMRI), Kenya; University of Gondar, Ethiopia; University of Makerere, Uganda.
We use cookies on our website to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to the use of all cookies. However, you may visit "Cookie Settings" to provide controlled consent.